חוב לטווח קצר של החברה: Know Labs Inc (KNW)

Know Labs, Inc. (KNW) management is focused on creating non-invasive glucose monitoring systems, although the market is awaiting FDA confirmation of efficacy. Meanwhile, the company relies on a dedicated staff of software and biosensor developers, supplementing them with AI specialists. The price action of securities with the 0.00 metric reflects the asset's dynamics. Product stability is ensured by the implementation of high-precision automated microelectronics assembly lines that eliminate human error.

For Know Labs, Inc., which deploys cloud telemetry and AI biosensors, financial obligations with a maturity of up to one year determine the ability to maintain an intensive R&D cycle without disrupting operational activities. This indicator measures the volume of borrowed capital used to cover current needs, allowing an investor to assess the liquidity balance and interest expense risk by analyzing the dynamics of the company's short-term debt.